Bahrain vs Sur: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Bahrain
99.0%
in 2025
Sur
0.0%
in 2025
Bahrain rank
1st
Sur rank
1st
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Bahrain
- Sur
How they compare
Bahrain currently reports 99.0% against 0.0% in Sur, a difference of 99.0%.
Across all 18 years both countries report, Bahrain has been ahead every year.
Bahrain ranks 1st and Sur ranks 1st of 194 countries.
Bahrain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 55.0% | 0.0% | 55.0% | Bahrain |
| 2010s | 98.3% | 0.0% | 98.3% | Bahrain |
| 2020s | 98.8% | 0.0% | 98.8% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Bahrain or Sur?
- Bahrain, at 99.0% against 0.0% in Sur as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Bahrain and Sur?
- 99.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Sur?
- 18 years are reported by both, from 2008 to 2025.
- How do Bahrain and Sur rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Bahrain ranks 1st and Sur ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.